Hepatoprotective evaluation of Anogeissus latifolia: In vitro and in vivo studies

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:zhhaibin
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM:To evaluate the hepatoprotective activity of a hydroalcoholic extract of the bark of Anogeissus latifolia; in vitro in primary rat hepatocyte monolayer culture and in vivo in the liver of Wistar rats intoxicated by carbon tetrachloride (CCl4).METHODS: In the in vitro study, a primary hepatocyte monolayer culture was treated with CCl4 and extract of Anogeissus latifolia. Hepatoprotective activity was demonstrated in the CCl4 damaged primary monolayer culture. In the in vivo study, the hepatoprotective activity of a hydroalcoholic extract of Anogeissus latifolia was analyzed in liver injured CCl4-treated rats. Biochemical parameters including serum transaminases [aspartate aminotransferase (AST) and alanine aminotransferase (ALT)] and alkaline phosphatase (ALP) in serum were analyzed. The biochemical findings were supplemented with histopathological examination of rat liver sections.RESULTS: In vitro: primary hepatocyte monolayer cultures were treated with CCl4 and extract of Anogeissus latifolia. A protective activity could be demonstrated in the CCl4 damaged primary monolayer culture. In vivo : Hydroalcoholic extract of Anogeissus latifolia (300 mg/kg) was found to have protective activity in rats with CCl4-induced liver damage as judged from serum marker enzyme activity.CONCLUSION: The above findings lead to the conclusion that the hydroalcoholic extract of Anogeissus latifolia is hepatoprotective. Hence, we suggest that the inclusion of this plant in the management of liver disorders is justified. AIM: To evaluate the hepatoprotective activity of a hydroalcoholic extract of the bark of Anogeissus latifolia; in vitro in primary rat hepatocyte monolayer culture and in vivo in the liver of Wistar rats intoxicated by carbon tetrachloride (CCl4). METHODS: In the in vitro study , a primary hepatocyte monolayer culture was treated with CCl4 and extract of Anogeissus latifolia. Hepatoprotective activity was demonstrated in the CCl4 damaged primary monolayer culture. In the in vivo study, the hepatoprotective activity of a hydroalcoholic extract of Anogeissus latifolia was analyzed in liver injured CCl4 -treated rats. Biochemical parameters including serum transaminases [aspartate aminotransferase (AST) and alanine aminotransferase (ALT)] and alkaline phosphatase (ALP) in serum were analyzed. The biochemical findings were supplemented with histopathological examination of rat liver sections. : primary hepatocyte monolayer cultures were treated with CCl4 and extract of Anogeis In vivo: Hydroalcoholic extract of Anogeissus latifolia (300 mg / kg) was found to have protective activity in rats with CCl4-induced liver damage as judged from serum marker enzyme activity. CONCLUSION: The above findings lead to the conclusion that the hydroalcoholic extract of Anogeissus latifolia is hepatoprotective. Therefore, we suggest that the inclusion of this plant in the management of liver disorders is justified.
其他文献
Bubble flow interaction can be important in many practical engineering applications. For instance, cavitation is a problem of interaction between nuclei and loc
Objective: To investigate the effect on erythroid differentiation and proliferation of K562 cells by IER3IP1-knockdown with RNA interference targeting at IER3IP
Objective: To investigate the mechanism of resistance to docetaxel in human lung cancer.Methods: Human lung carcinoma SPC-A1/Docetaxel cells were derived from p
The inclusion interaction between berberine hydrochloride (BRH) and cucurbit[7] (CB[7]) has been studied by spectro-fluorimetry. The result showed that CB[7] in
射频脉冲的频率选择性直接影响磁共振成像的质量,而射频脉冲的优化设计又归结为对Bloch方程的求解.尽管在某些情况下Bloch方程存在解析解,但由于其缺乏通用性而且形式上过于
AIM: To determine risk factors for pulmonary embolism and estimate effects and benefits of prophylaxis.METHODS: We included 78 patients who died subsequently to
Celiac disease has been associated with some autoimmune disorders. A 40-year-old competitive strongman with celiac disease responded to a glutenfree diet, but d
Background Target-controlled infusion (TCI) has been recently developed and successfully implemented in clinical practice. This study was conducted to determine